Amyotrophic Lateral Sclerosis as a Spatiotemporal Mislocalization Disease: Location, Location, Location

International Review of Cell and Molecular Biology

Volumn 315, Issue , 2015, Pages 23-71

  Gershoni Emek, Noga ^a   Chein, Michael ^a   Gluska, Shani ^a   Perlson, Eran ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ALS; Axonal transport; Local synthesis; Neurotrophic factors; Spatiotemporal localization

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOPLASMIC DYNEIN; DEATH RECEPTOR; DEATH RECEPTOR 6; DNA BINDING PROTEIN; FAS LIGAND; GLYCOGEN SYNTHASE KINASE 3; KINESIN; MICRORNA; MOLECULAR MOTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN SERINE THREONINE KINASE; RETINOL BINDING PROTEIN; RNA BINDING PROTEIN; SEMAPHORIN; STATHMIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ACTIN FILAMENT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DEATH; CELL INCLUSION; CHROMOSOME 9; CLINICAL RESEARCH; CYTOSKELETON; DEGENERATIVE DISEASE; DISEASE COURSE; DNA BINDING; ENZYME ACTIVITY; GENE MUTATION; HUMAN; INTRACELLULAR TRANSPORT; MISSENSE MUTATION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MOTONEURON; MOTOR PERFORMANCE; NERVE FIBER TRANSPORT; NEUROMUSCULAR SYNAPSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SPATIOTEMPORAL ANALYSIS; ANIMAL; METABOLISM; PATHOLOGY; TIME;

AMYLOID BETA-PROTEIN PRECURSOR; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONAL TRANSPORT; HUMANS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84923192954     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2014.11.003     Document Type: Article

References (252)

1. Aebischer J., Cassina P., Otsmane B., Moumen A., Seilhean D., Meininger V., Barbeito L., Pettmann B., Raoul C. IFNgamma triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1. Cell Death Differ. 2011, 18:754-768.
2. Alami N.H., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A., Clare A.J., Badders N.M., Bilican B., Chaum E., Chandran S., Shaw C.E., Eggan K.C., Maniatis T., Taylor J.P. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron 2014, 81:536-543.
3. Aoki N., Higashi S., Kawakami I., Kobayashi Z., Hosokawa M., Katsuse O., Togo T., Hirayasu Y., Akiyama H. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain. Acta Neuropathol. 2012, 124:383-394.
4. Ash P.E., Zhang Y.J., Roberts C.M., Saldi T., Hutter H., Buratti E., Petrucelli L., Link C.D. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum. Mol. Genet. 2010, 19:3206-3218.
5. Ayala Y.M., De Conti L., Avendano-Vazquez S.E., Dhir A., Romano M., D'Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., Baralle F.E. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011, 30:277-288.
6. Ayala Y.M., Zago P., D'Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008, 121:3778-3785.
7. Ayloo S., Lazarus J.E., Dodda A., Tokito M., Ostap E.M., Holzbaur E.L. Dynactin functions as both a dynamic tether and brake during dynein-driven motility. Nat. Commun. 2014, 5:4807.
8. Babin P.J., Goizet C., Raldua D. Zebrafish models of human motor neuron diseases: advantages and limitations. Prog. Neurobiol. 2014, 118:36-58.
9. Banks G.T., Fisher E.M. Cytoplasmic dynein could be key to understanding neurodegeneration. Genome Biol. 2008, 9:214.
10. Baron D.M., Kaushansky L.J., Ward C.L., Sama R.R., Chian R.J., Boggio K.J., Quaresma A.J., Nickerson J.A., Bosco D.A. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics. Mol. Neurodegener. 2013, 8:30.
11. Bartolome F., Wu H.C., Burchell V.S., Preza E., Wray S., Mahoney C.J., Fox N.C., Calvo A., Canosa A., Moglia C., Mandrioli J., Chio A., Orrell R.W., Houlden H., Hardy J., Abramov A.Y., Plun-Favreau H. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 2013, 78:57-64.
12. Beaulieu J.M., Nguyen M.D., Julien J.P. Late onset of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 1999, 147:531-544.
13. Ben-Zvi A., Manor O., Schachner M., Yaron A., Tessier-Lavigne M., Behar O. The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal root ganglia development. J. Neurosci.: Off. J. Soc. Neurosci. 2008, 28:12427-12432.
14. Benschop R., Wei T., Na S. Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6. Adv. Exp. Med. Biol. 2009, 647:186-194.
15. Bernard-Marissal N., Moumen A., Sunyach C., Pellegrino C., Dudley K., Henderson C.E., Raoul C., Pettmann B. Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS. J. Neurosci.: Off. J. Soc. Neurosci. 2012, 32:4901-4912.
16. Bilsland L.G., Sahai E., Kelly G., Golding M., Greensmith L., Schiavo G. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. USA 2010, 107:20523-20528.
17. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 2004, 101:2173-2178.
18. Boulting G.L., Kiskinis E., Croft G.F., Amoroso M.W., Oakley D.H., Wainger B.J., Williams D.J., Kahler D.J., Yamaki M., Davidow L., Rodolfa C.T., Dimos J.T., Mikkilineni S., MacDermott A.B., Woolf C.J., Henderson C.E., Wichterle H., Eggan K. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 2011, 29:279-286.
19. Brickley K., Stephenson F.A. Trafficking kinesin protein (TRAK)-mediated transport of mitochondria in axons of hippocampal neurons. J. Biol. Chem. 2011, 286:18079-18092.
20. Bronfman F.C., Fainzilber M. Multi-tasking by the p75 neurotrophin receptor: sortilin things out?. EMBO Rep. 2004, 5:867-871.
21. Bruneteau G., Simonet T., Bauche S., Mandjee N., Malfatti E., Girard E., Tanguy M.L., Behin A., Khiami F., Sariali E., Hell-Remy C., Salachas F., Pradat P.F., Fournier E., Lacomblez L., Koenig J., Romero N.B., Fontaine B., Meininger V., Schaeffer L., Hantai D. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain: J. Neurol. 2013, 136:2359-2368.
22. Bryson J.B., Hobbs C., Parsons M.J., Bosch K.D., Pandraud A., Walsh F.S., Doherty P., Greensmith L. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012, 21:3871-3882.
23. Buratti E., Baralle F.E. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 2010, 7:420-429.
24. Buratti E., De Conti L., Stuani C., Romano M., Baralle M., Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010, 277:2268-2281.
25. Butowt R., von Bartheld C.S. Fates of neurotrophins after retrograde axonal transport: phosphorylation of p75NTR is a sorting signal for delayed degradation. J.Neurosci.: Off. J. Soc. Neurosci. 2009, 29:10715-10729.
26. Cai Q., Gerwin C., Sheng Z.H. Syntabulin-mediated anterograde transport of mitochondria along neuronal processes. J. Cell Biol. 2005, 170:959-969.
27. Calingasan N.Y., Chen J., Kiaei M., Beal M.F. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol. Dis. 2005, 19:340-347.
28. Campenot R.B., MacInnis B.L. Retrograde transport of neurotrophins: fact and function. J. Neurobiol. 2004, 58:217-229.
29. Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol. Brain 2013, 6:26.
30. Camu W., Tremblier B., Plassot C., Alphandery S., Salsac C., Pageot N., Juntas-Morales R., Scamps F., Daures J.P., Raoul C. Vitamin D confers protection to motoneurons and is a prognostic factor of amyotrophic lateral sclerosis. Neurobiol. Aging 2014, 35:1198-1205.
31. Cao P., Zhang W., Gui W., Dong Y., Jiang T., Gong Y. Structural insights into the mechanism of calmodulin binding to death receptors. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2014, 70:1604-1613.
32. Chao M.V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 2003, 4:299-309.
33. Charbaut E., Curmi P.A., Ozon S., Lachkar S., Redeker V., Sobel A. Stathmin family proteins display specific molecular and tubulin binding properties. J. Biol. Chem. 2001, 276:16146-16154.
34. Chen H., Qian K., Du Z., Cao J., Petersen A., Liu H., Blackbourn L.W.t., Huang C.L., Errigo A., Yin Y., Lu J., Ayala M., Zhang S.C. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 2014, 14:796-809.
35. Chen X.J., Levedakou E.N., Millen K.J., Wollmann R.L., Soliven B., Popko B. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic Dynein heavy chain 1 gene. J. Neurosci.: Off. J. Soc. Neurosci. 2007, 27:14515-14524.
36. Chestkov I.V., Vasilieva E.A., Illarioshkin S.N., Lagarkova M.A., Kiselev S.L. Patient-specific induced pluripotent stem cells for SOD1-associated amyotrophic lateral sclerosis pathogenesis studies. Acta Naturae 2014, 6:54-60.
37. Chevalier-Larsen E., Holzbaur E.L. Axonal transport and neurodegenerative disease. Biochim. Biophys. acta 2006, 1762:1094-1108.
38. Cooper-Knock J., Walsh M.J., Higginbottom A., Robin Highley J., Dickman M.J., Edbauer D., Ince P.G., Wharton S.B., Wilson S.A., Kirby J., Hautbergue G.M., Shaw P.J. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain: J. Neurol. 2014, 137:2040-2051.
39. Corrado L., Carlomagno Y., Falasco L., Mellone S., Godi M., Cova E., Cereda C., Testa L., Mazzini L., D'Alfonso S. A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient. Neurobiol. Aging 2011, 32:552e551-552e556.
40. Courchesne S.L., Pazyra-Murphy M.F., Lee D.J., Segal R.A. Neuromuscularjunction defects in mice with mutation of dynein heavy chain 1. PloS One 2011, 6:e16753.
41. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993, 363:640-644.
42. Dadon-Nachum M., Ben-Yaacov K., Ben-Zur T., Barhum Y., Yaffe D., Perlson E., Offen D. Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 Mouse Model of ALS. J. Mol. Neurosci 2014.
43. Daigle J.G., Lanson N.A., Smith R.B., Casci I., Maltare A., Monaghan J., Nichols C.D., Kryndushkin D., Shewmaker F., Pandey U.B. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum. Mol. Genet. 2013, 22:1193-1205.
44. De Marco G., Lupino E., Calvo A., Moglia C., Buccinna B., Grifoni S., Ramondetti C., Lomartire A., Rinaudo M.T., Piccinini M., Giordana M.T., Chio A. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol. 2011, 121:611-622.
45. De Winter F., Vo T., Stam F.J., Wisman L.A., Bar P.R., Niclou S.P., van Muiswinkel F.L., Verhaagen J. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell. Neurosci. 2006, 32:102-117.
46. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
47. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
48. Ding Y., Tian M., Liu J., Deng Y., Li W., Feng X., Hou D. Expression profile of miRNAs in APP swe/PSDeltaE9 transgenic mice. Nan fang yi ke da xue xue bao=J. South. Med. Univ. 2012, 32:1280-1283.
49. Dini Modigliani S., Morlando M., Errichelli L., Sabatelli M., Bozzoni I. An ALS-associated mutation in the FUS 3'-UTR disrupts a microRNA-FUS regulatory circuitry. Nat. Commun. 2014, 5:4335.
50. Dodge J.C., Treleaven C.M., Fidler J.A., Hester M., Haidet A., Handy C., Rao M., Eagle A., Matthews J.C., Taksir T.V., Cheng S.H., Shihabuddin L.S., Kaspar B.K. AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice. Mol. Ther.: J. Am. Soc. Gene Ther. 2010, 18:2075-2084.
51. Dompierre J.P., Godin J.D., Charrin B.C., Cordelieres F.P., King S.J., Humbert S., Saudou F. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J. Neurosci.: Off. J. Soc. Neurosci. 2007, 27:3571-3583.
52. Donnelly C.J., Zhang P.W., Pham J.T., Haeusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., Maragakis N., Tienari P.J., Petrucelli L., Traynor B.J., Wang J., Rigo F., Bennett C.F., Blackshaw S., Sattler R., Rothstein J.D. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 2013, 80:415-428.
53. Dormann D., Haass C. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol. Cell. Neurosci. 2013, 56:475-486.
54. El-Kadi A.M., Bros-Facer V., Deng W., Philpott A., Stoddart E., Banks G., Jackson G.S., Fisher E.M., Duchen M.R., Greensmith L., Moore A.L., Hafezparast M. The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease. J. Biol. Chem. 2010, 285:18627-18639.
55. Fanara P., Banerjee J., Hueck R.V., Harper M.R., Awada M., Turner H., Husted K.H., Brandt R., Hellerstein M.K. Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis. J. Biol. Chem. 2007, 282:23465-23472.
56. Fanara P., Wong P.Y., Husted K.H., Liu S., Liu V.M., Kohlstaedt L.A., Riiff T., Protasio J.C., Boban D., Killion S., Killian M., Epling L., Sinclair E., Peterson J., Price R.W., Cabin D.E., Nussbaum R.L., Bruhmann J., Brandt R., Christine C.W., Aminoff M.J., Hellerstein M.K. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J. Clin. Invest. 2012, 122:3159-3169.
57. Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R.A., Levina V., Halloran M.A., Gleeson P.A., Blair I.P., Soo K.Y., King A.E., Atkin J.D. C9ORF72, implicated in amyotrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 2014, 23:3579-3595.
58. Farrer M.J., Hulihan M.M., Kachergus J.M., Dachsel J.C., Stoessl A.J., Grantier L.L., Calne S., Calne D.B., Lechevalier B., Chapon F., Tsuboi Y., Yamada T., Gutmann L., Elibol B., Bhatia K.P., Wider C., Vilarino-Guell C., Ross O.A., Brown L.A., Castanedes-Casey M., Dickson D.W., Wszolek Z.K. DCTN1 mutations in Perry syndrome. Nat. Genet. 2009, 41:163-165.
59. Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci.: Off. J. Soc. Neurosci. 2007, 27:9201-9219.
60. Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathwaysof motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011, 7:616-630.
61. Franker M.A., Hoogenraad C.C. Microtubule-based transport - basic mechanisms, traffic rules and role in neurological pathogenesis. J. Cell Sci. 2013, 126:2319-2329.
62. Fransson S., Ruusala A., Aspenstrom P. The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem. Biophys. Res. Commun. 2006, 344:500-510.
63. Friedman W.J., Greene L.A. Neurotrophin signaling via Trks and p75. Exp. Cell Res. 1999, 253:131-142.
64. Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., Nishikawa T., Hicks G.G., Takumi T. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol.: CB 2005, 15:587-593.
65. Fujii R., Takumi T. TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 2005, 118:5755-5765.
66. Fujita H., Zhang B., Sato K., Tanaka J., Sakanaka M. Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Res. 2001, 914:1-14.
67. Gaiottino J., Norgren N., Dobson R., Topping J., Nissim A., Malaspina A., Bestwick J.P., Monsch A.U., Regeniter A., Lindberg R.L., Kappos L., Leppert D., Petzold A., Giovannoni G., Kuhle J. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PloS One 2013, 8:e75091.
68. Gal J., Chen J., Barnett K.R., Yang L., Brumley E., Zhu H. HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation. J. Biol. Chem. 2013, 288:15035-15045.
69. Gardiol A., St Johnston D. Staufen targets coracle mRNA to Drosophila neuromuscular junctions and regulates GluRIIA synaptic accumulation and bouton number. Dev. Biol. 2014, 392:153-167.
70. Ginty D.D., Segal R.A. Retrograde neurotrophin signaling: Trk-ing along the axon. Curr. Opin. Neurobiol. 2002, 12:268-274.
71. Giordana M.T., Piccinini M., Grifoni S., De Marco G., Vercellino M., Magistrello M., Pellerino A., Buccinna B., Lupino E., Rinaudo M.T. TDP-43 redistributionis an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 2010, 20:351-360.
72. Glater E.E., Megeath L.J., Stowers R.S., Schwarz T.L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell Biol. 2006, 173:545-557.
73. Gluska S., Zahavi E.E., Chein M., Gradus T., Bauer A., Finke S., Perlson E. Rabies Virus Hijacks and Accelerates the p75NTR Retrograde Axonal Transport Machinery. PLoS pathogens 2014, 10:e1004348.
74. Goldsteins G., Keksa-Goldsteine V., Ahtoniemi T., Jaronen M., Arens E., Akerman K., Chan P.H., Koistinaho J. Deleterious role of superoxide dismutase in the mitochondrial intermembrane space. J. Biol. Chem. 2008, 283:8446-8452.
75. Good P.F., Alapat D., Hsu A., Chu C., Perl D., Wen X., Burstein D.E., Kohtz D.S. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J. Neurochem. 2004, 91:716-736.
76. Goshima Y., Hori H., Sasaki Y., Yang T., Kagoshima-Maezono M., Li C., Takenaka T., Nakamura F., Takahashi T., Strittmatter S.M., Misu Y., Kawakami T. Growth cone neuropilin-1 mediates collapsin-1/Sema III facilitation of antero- and retrograde axoplasmic transport. J. Neurobiol. 1999, 39:579-589.
77. Gould T.W., Oppenheim R.W. Motor neuron trophic factors: therapeutic use in ALS?. Brain Res. Rev. 2011, 67:1-39.
78. Graf E.R., Heerssen H.M., Wright C.M., Davis G.W., DiAntonio A. Stathmin is required for stability of the Drosophila neuromuscular junction. J. Neurosci.: Off. J. Soc. Neurosci. 2011, 31:15026-15034.
79. Graffmo K.S., Forsberg K., Bergh J., Birve A., Zetterstrom P., Andersen P.M., Marklund S.L., Brannstrom T. Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013, 22:51-60.
80. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
81. Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D.A., Trotti D., Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA 2012, 109:5074-5079.
82. Guipponi M., Li Q.X., Hyde L., Beissbarth T., Smyth G.K., Masters C.L., Scott H.S. SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. J. Mol. Neurosci.: MN 2010, 41:172-182.
83. Guo X., Macleod G.T., Wellington A., Hu F., Panchumarthi S., Schoenfield M., Marin L., Charlton M.P., Atwood H.L., Zinsmaier K.E. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005, 47:379-393.
84. Haase G., Pettmann B., Raoul C., Henderson C.E. Signaling by death receptors in the nervous system. Curr. Opin. Neurobiol. 2008, 18:284-291.
85. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003, 300:808-812.
86. Haramati S., Chapnik E., Sztainberg Y., Eilam R., Zwang R., Gershoni N., McGlinn E., Heiser P.W., Wills A.M., Wirguin I., Rubin L.L., Misawa H., Tabin C.J., Brown R., Chen A., Hornstein E. miRNA malfunctioncauses spinal motor neuron disease. Proc. Natl. Acad. Sci. USA 2010, 107:13111-13116.
87. Haulcomb M.M., Mesnard N.A., Batka R.J., Alexander T.D., Sanders V.M., Jones K.J. Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice. J. Comp. Neurol. 2014, 522:2349-2376.
88. Henriques A., Pitzer C., Schneider A. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?. Front. Neurosci. 2010, 4:32.
89. Herman A.M., Khandelwal P.J., Stanczyk B.B., Rebeck G.W., Moussa C.E. beta-amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Res. 2011, 1386:191-199.
90. Heutink P., Jansen I.E., Lynes E.M. C9orf72; abnormal RNA expression is the key. Exp. Neurol 2014, 262PB:102-110.
91. Hibbert A.P., Kramer B.M., Miller F.D., Kaplan D.R. The localization, trafficking and retrograde transport of BDNF bound to p75NTR in sympathetic neurons. Mol. Cell. Neurosci. 2006, 32:387-402.
92. Hinckelmann M.V., Zala D., Saudou F. Releasing the brake: restoring fast axonal transport in neurodegenerative disorders. Trends Cell Biol. 2013, 23:634-643.
93. Hooper C., Killick R., Lovestone S. The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 2008, 104:1433-1439.
94. Howe C.L., Mobley W.C. Signaling endosome hypothesis: a cellular mechanism for long distance communication. J. Neurobiol. 2004, 58:207-216.
95. Hu R., Du Q., Yin X., Li J., Wang T., Zhang L. Agonist antibody activates death receptor 6 downstream signaling involving TRADD recruitment. FEBS Lett. 2014, 588:401-407.
96. Hu Y., Lee X., Shao Z., Apicco D., Huang G., Gong B.J., Pepinsky R.B., Mi S. A DR6/p75(NTR) complex is responsible for beta-amyloid-induced cortical neuron death. Cell Death Dis. 2013, 4:e579.
97. Huang G., Lee X., Bian Y., Shao Z., Sheng G., Pepinsky R.B., Mi S. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis. Cell Death Dis. 2013, 4:e841.
98. Huang J., Roberts A.J., Leschziner A.E., Reck-Peterson S.L. Lis1 acts as a "clutch" between the ATPase and microtubule-binding domains of the dynein motor. Cell 2012, 150:975-986.
99. Hubbert C., Guardiola A., Shao R., Kawaguchi Y., Ito A., Nixon A., Yoshida M., Wang X.F., Yao T.P. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417:455-458.
100. Hwang D.H., Lee H.J., Park I.H., Seok J.I., Kim B.G., Joo I.S., Kim S.U. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther. 2009, 16:1234-1244.
101. Ibanez C.F., Simi A. p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci. 2012, 35:431-440.
102. Ilieva H.S., Yamanaka K., Malkmus S., Kakinohana O., Yaksh T., Marsala M., Cleveland D.W. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc. Natl. Acad. Sci. USA 2008, 105:12599-12604.
103. Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010, 67:575-587.
104. Jablonka S., Dombert B., Asan E., Sendtner M. Mechanisms for axon maintenance and plasticity in motoneurons: alterations in motoneuron disease. J. Anat. 2014, 224:3-14.
105. Jaiswal M., Sandoval H., Zhang K., Bayat V., Bellen H.J. Probing mechanisms that underlie human neurodegenerative diseases in Drosophila. Annu. Rev. Genet. 2012, 46:371-396.
106. Jeong G.B., Mojsilovic-Petrovic J., Boccitto M., Kalb R. Signaling events in axons and/or dendrites render motor neurons vulnerable to mutant superoxide dismutase toxicity. J. Neurosci.: Off. J. Soc. Neurosci. 2011, 31:295-299.
107. Jiang Y.M., Yamamoto M., Tanaka F., Ishigaki S., Katsuno M., Adachi H., Niwa J., Doyu M., Yoshida M., Hashizume Y., Sobue G. Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2007, 66:617-627.
108. Jin J., Cheng Y., Zhang Y., Wood W., Peng Q., Hutchison E., Mattson M.P., Becker K.G., Duan W. Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J. Neurochem. 2012, 123:477-490.
109. Jouroukhin Y., Ostritsky R., Assaf Y., Pelled G., Giladi E., Gozes I. NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport. Neurobiol. Dis. 2013, 56:79-94.
110. Julien J.P., Beaulieu J.M. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?. J. Neurol. Sci. 2000, 180:7-14.
111. Kallop D.Y., Meilandt W.J., Gogineni A., Easley-Neal C., Wu T., Jubb A.M., Yaylaoglu M., Shamloo M., Tessier-Lavigne M., Scearce-Levie K., Weimer R.M. A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models. J. Neurosci.: Off. J. Soc. Neurosci. 2014, 34:6425-6437.
112. Kamal A., Stokin G.B., Yang Z., Xia C.H., Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 2000, 28:449-459.
113. Kanai Y., Dohmae N., Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 2004, 43:513-525.
114. Kaneko S., Iwanami A., Nakamura M., Kishino A., Kikuchi K., Shibata S., Okano H.J., Ikegami T., Moriya A., Konishi O., Nakayama C., Kumagai K., Kimura T., Sato Y., Goshima Y., Taniguchi M., Ito M., He Z., Toyama Y., Okano H. A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med. 2006, 12:1380-1389.
115. Kang J.S., Tian J.H., Pan P.Y., Zald P., Li C., Deng C., Sheng Z.H. Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 2008, 132:137-148.
116. Kapitein L.C., Hoogenraad C.C. Which way to go? Cytoskeletal organization and polarized transport in neurons. Mol. Cell. Neurosci. 2011, 46:9-20.
117. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10:381-391.
118. Kenchappa R.S., Zampieri N., Chao M.V., Barker P.A., Teng H.K., Hempstead B.L., Carter B.D. Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 2006, 50:219-232.
119. Kieran D., Hafezparast M., Bohnert S., Dick J.R., Martin J., Schiavo G., Fisher E.M., Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 2005, 169:561-567.
120. Kim N.C., Andrews P.C., Asselbergs F.W., Frost H.R., Williams S.M., Harris B.T., Read C., Askland K.D., Moore J.H. Gene ontology analysis of pairwisegenetic associations in two genome-wide studies of sporadic ALS. BioData Min. 2012, 5:9.
121. Kim S.H., Shanware N.P., Bowler M.J., Tibbetts R.S. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 2010, 285:34097-34105.
122. King I., Yartseva V., Salas D., Kumar A., Heidersbach A., Ando D.M., Stallings N.R., Elliott J.L., Srivastava D., Ivey K.N. The RNA binding protein TDP-43 selectively disrupts MicroRNA-1/206 incorporation into the RNA-induced silencing complex. J. Biol. Chem 2014, 289:14263-14271.
123. Kiskinis E., Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 2010, 120:51-59.
124. Ko J.A., Mizuno Y., Shibasaki M., Yamane K., Chikama T., Sonoda K.H., Kiuchi Y. Differential expression of semaphorin 3A and its receptors during mouse retinal development. Cell Biochem. Funct. 2012, 30:563-568.
125. Koh S.H., Baek W., Kim S.H. Brief review of the role of glycogen synthase kinase-3beta in amyotrophic lateral sclerosis. Neurol. Res. Int. 2011, 2011:205761.
126. Kuroda M., Sok J., Webb L., Baechtold H., Urano F., Yin Y., Chung P., de Rooij D.G., Akhmedov A., Ashley T., Ron D. Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J. 2000, 19:453-462.
127. Kust B.M., Brouwer N., Mantingh I.J., Boddeke H.W., Copray J.C. Reduced p75NTR expression delays disease onset only in female mice of a transgenic model of familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord.: Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2003, 4:100-105.
128. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
129. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:R46-R64.
130. Laird F.M., Farah M.H., Ackerley S., Hoke A., Maragakis N., Rothstein J.D., Griffin J., Price D.L., Martin L.J., Wong P.C. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J. Neurosci.: Off. J. Soc. Neurosci. 2008, 28:1997-2005.
131. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002, 34:715-727.
132. Lazarov O., Morfini G.A., Lee E.B., Farah M.H., Szodorai A., DeBoer S.R., Koliatsos V.E., Kins S., Lee V.M., Wong P.C., Price D.L., Brady S.T., Sisodia S.S. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci.: Off. J. Soc. Neurosci. 2005, 25:2386-2395.
133. Lee S.T., Chu K., Jung K.H., Kim J.H., Huh J.Y., Yoon H., Park D.K., Lim J.Y., Kim J.M., Jeon D., Ryu H., Lee S.K., Kim M., Roh J.K. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann. Neurol. 2012, 72:269-277.
134. Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013, 201:361-372.
135. Ligon L.A., Shelly S.S., Tokito M., Holzbaur E.L. The microtubule plus-end proteins EB1 and dynactin have differential effects on microtubule polymerization. Mol. Biol. Cell 2003, 14:1405-1417.
136. Lilo E., Wald-Altman S., Solmesky L.J., Ben Yaakov K., Gershoni-Emek N., Bulvik S., Kassis I., Karussis D., Perlson E., Weil M. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model. Hum. Mol. Genet. 2013, 22:4720-4725.
137. Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brannstrom T., Gredal O., Wong P.C., Williams D.S., Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 2004, 43:5-17.
138. Liu J.X., Brannstrom T., Andersen P.M., Pedrosa-Domellof F. Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors. PloS One 2013, 8:e57473.
139. Lloyd T.E., Machamer J., O'Hara K., Kim J.H., Collins S.E., Wong M.Y., Sahin B., Imlach W., Yang Y., Levitan E.S., McCabe B.D., Kolodkin A.L. The p150(Glued) CAP-Gly domain regulates initiation of retrograde transport at synaptic termini. Neuron 2012, 74:344-360.
140. Locatelli F., Corti S., Papadimitriou D., Fortunato F., Del Bo R., Donadoni C., Nizzardo M., Nardini M., Salani S., Ghezzi S., Strazzer S., Bresolin N., Comi G.P. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice. Ann. Neurol. 2007, 62:81-92.
141. Lowry K.S., Murray S.S., McLean C.A., Talman P., Mathers S., Lopes E.C., Cheema S.S. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord.: Off. Publ. World Fed. Neurology, Res. Group Mot. Neuron Dis. 2001, 2:127-134.
142. Lu B., Pang P.T., Woo N.H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci. 2005, 6:603-614.
143. Lu C.H., Petzold A., Topping J., Allen K., Macdonald-Wallis C., Clarke J., Pearce N., Kuhle J., Giovannoni G., Fratta P., Sidle K., Fish M., Orrell R., Howard R., Greensmith L., Malaspina A. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J. Neurol. Neurosurg. Psychiatry 2014.
144. Machamer J.B., Collins S.E., Lloyd T.E. The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction. Hum. Mol. Genet. 2014, 23:3810-3822.
145. Maeder C.I., Shen K., Hoogenraad C.C. Axon and dendritic trafficking. Curr. Opin. Neurobiol. 2014, 27C:165-170.
146. Majed H.H., Chandran S., Niclou S.P., Nicholas R.S., Wilkins A., Wing M.G., Rhodes K.E., Spillantini M.G., Compston A. A novel role for Sema3A in neuroprotection from injury mediated by activated microglia. J. Neurosci.: Off. J. Soc. Neurosci. 2006, 26:1730-1738.
147. Maor-Nof M., Homma N., Raanan C., Nof A., Hirokawa N., Yaron A. Axonal pruning is actively regulated by the microtubule-destabilizing protein kinesin superfamily protein 2A. Cell Rep. 2013, 3:971-977.
148. Martin K.C., Ephrussi A. mRNA localization: gene expression in the spatial dimension. Cell 2009, 136:719-730.
149. Matsushita K., Wu Y., Qiu J., Lang-Lazdunski L., Hirt L., Waeber C., Hyman B.T., Yuan J., Moskowitz M.A. Fas receptor and neuronal cell death after spinal cord ischemia. J. Neurosci.: Off. J. Soc. Neurosci. 2000, 20:6879-6887.
150. Maximino J.R., de Oliveira G.P., Alves C.J., Chadi G. Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) amyotrophic lateral sclerosis mouse model. Front. Cell. Neurosci. 2014, 8:148.
151. McGoldrick P., Joyce P.I., Fisher E.M., Greensmith L. Rodent models of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2013, 1832:1421-1436.
152. McKenney R.J., Huynh W., Tanenbaum M.E., Bhabha G., Vale R.D. Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes. Science 2014, 345:337-341.
153. Meignin C., Davis I. Transmitting the message: intracellular mRNA localization. Curr. Opin. Cell Biol. 2010, 22:112-119.
154. Merrill R.A., Strack S. Mitochondria: a kinase anchoring protein 1, a signaling platform for mitochondrial form and function. Int. J. Biochem. Cell Biol. 2014, 48:92-96.
155. Michaelevski I., Medzihradszky K.F., Lynn A., Burlingame A.L., Fainzilber M. Axonal transport proteomics reveals mobilization of translation machinery to the lesion site in injured sciatic nerve. Mol. Cell. Proteomics: MCP 2010, 9:976-987.
156. Mili S., Macara I.G. RNA localization and polarity: from A(PC) to Z(BP). Trends Cell Biol. 2009, 19:156-164.
157. Millecamps S., Julien J.P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 2013, 14:161-176.
158. Millecamps S., Robertson J., Lariviere R., Mallet J., Julien J.P. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin. J. Neurochem. 2006, 98:926-938.
159. Morfini G.A., Bosco D.A., Brown H., Gatto R., Kaminska A., Song Y., Molla L., Baker L., Marangoni M.N., Berth S., Tavassoli E., Bagnato C., Tiwari A., Hayward L.J., Pigino G.F., Watterson D.M., Huang C.F., Banker G., Brown R.H., Brady S.T. Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PloS One 2013, 8:e65235.
160. Mori K., Lammich S., Mackenzie I.R., Forne I., Zilow S., Kretzschmar H., Edbauer D., Janssens J., Kleinberger G., Cruts M., Herms J., Neumann M., Van Broeckhoven C., Arzberger T., Haass C. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol. 2013, 125:413-423.
161. Morlando M., Dini Modigliani S., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012, 31:4502-4510.
162. Moughamian A.J., Holzbaur E.L. Dynactin is required for transport initiation from the distal axon. Neuron 2012, 74:331-343.
163. Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., Prudlo J., Peraus G., Hanemann C.O., Stumm G., Ludolph A.C. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004, 63:724-726.
164. Nagahara A.H., Tuszynski M.H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 2011, 10:209-219.
165. Nakamura F., Kalb R.G., Strittmatter S.M. Molecular basis of semaphorin-mediated axon guidance. J. Neurobiol. 2000, 44:219-229.
166. Nguyen T.T., Oh S.S., Weaver D., Lewandowska A., Maxfield D., Schuler M.H., Smith N.K., Macfarlane J., Saunders G., Palmer C.A., Debattisti V., Koshiba T., Pulst S., Feldman E.L., Hajnoczky G., Shaw J.M. Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease. Proc. Natl. Acad. Sci. USA 2014, 111:E3631-E3640.
167. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
168. Panov A., Kubalik N., Zinchenko N., Hemendinger R., Dikalov S., Bonkovsky H.L. Respiration and ROS production in brain and spinal cord mitochondria of transgenic rats with mutant G93a Cu/Zn-superoxide dismutase gene. Neurobiol. Dis. 2011, 44:53-62.
169. Park J., Koito H., Li J., Han A. Multi-compartment neuron-glia co-culture platform for localized CNS axon-glia interaction study. Lab chip 2012, 12:3296-3304.
170. Pearson H.A., Peers C. Physiological roles for amyloid beta peptides. J. Physiol. 2006, 575:5-10.
171. Pedrini S., Sau D., Guareschi S., Bogush M., Brown R.H., Naniche N., Kia A., Trotti D., Pasinelli P. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum. Mol. Genet. 2010, 19:2974-2986.
172. Perlson E., Hanz S., Ben-Yaakov K., Segal-Ruder Y., Seger R., Fainzilber M. Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron 2005, 45:715-726.
173. Perlson E., Hendricks A.G., Lazarus J.E., Ben-Yaakov K., Gradus T., Tokito M., Holzbaur E.L. Dynein interacts with the neural cell adhesion molecule (NCAM180) to tether dynamic microtubules and maintain synaptic density in cortical neurons. J. Biol. Chem. 2013, 288:27812-27824.
174. Perlson E., Jeong G.B., Ross J.L., Dixit R., Wallace K.E., Kalb R.G., Holzbaur E.L. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 2009, 29:9903-9917.
175. Petri S., Kiaei M., Wille E., Calingasan N.Y., Flint Beal M. Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice. J. Neurol. Sci. 2006, 251:44-49.
176. Pilling A.D., Horiuchi D., Lively C.M., Saxton W.M. Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons. Mol. Biol. Cell 2006, 17:2057-2068.
177. Poppe L., Rue L., Robberecht W., Van Den Bosch L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Exp. Neurol 2014, 262PB:138-151.
178. Puentes F., Topping J., Kuhle J., van der Star B.J., Douiri A., Giovannoni G., Baker D., Amor S., Malaspina A. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2014, 85:274-278.
179. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown R.H., Ludlow C.L., Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat. Genet. 2003, 33:455-456.
180. Rabbitts T.H., Forster A., Larson R., Nathan P. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 1993, 4:175-180.
181. Radzikinas K., Aven L., Jiang Z., Tran T., Paez-Cortez J., Boppidi K., Lu J., Fine A., Ai X. A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle. J. Neurosci.: Off. J. Soc. Neurosci. 2011, 31:15407-15415.
182. Raoul C., Estevez A.G., Nishimune H., Cleveland D.W., deLapeyriere O., Henderson C.E., Haase G., Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 2002, 35:1067-1083.
183. Reddy K., Zamiri B., Stanley S.Y., Macgregor R.B., Pearson C.E. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem. 2013, 288:9860-9866.
184. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
185. Riccio A., Pierchala B.A., Ciarallo C.L., Ginty D.D. An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 1997, 277:1097-1100.
186. Rice S.E., Gelfand V.I. Paradigm lost: milton connects kinesin heavy chain to miro on mitochondria. J. Cell Biol. 2006, 173:459-461.
187. Rodriguez-Gonzalez A., Lin T., Ikeda A.K., Simms-Waldrip T., Fu C., Sakamoto K.M. Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation. Cancer Res. 2008, 68:2557-2560.
188. Russo G.J., Louie K., Wellington A., Macleod G.T., Hu F., Panchumarthi S., Zinsmaier K.E. Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. J. Neurosci.: Off. J. Soc. Neurosci. 2009, 29:5443-5455.
189. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70:1033-1053.
190. Schwartz J.C., Podell E.R., Han S.S., Berry J.D., Eggan K.C., Cech T.R. FUS is sequestered in nuclear aggregates in ALS patient fibroblasts. Mol. Biol. Cell 2014, 25(17):2571-2578.
191. Schwarz T.L. Mitochondrial trafficking in neurons. Cold Spring Harbor perspectives in biology 5 2013.
192. Seeburger J.L., Tarras S., Natter H., Springer J.E. Spinal cord motoneurons express p75NGFR and p145trkB mRNA in amyotrophic lateral sclerosis. Brain Res. 1993, 621:111-115.
193. Segal R.A. Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 2003, 26:299-330.
194. Selvaraj B.T., Frank N., Bender F.L., Asan E., Sendtner M. Local axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron disease. J. Cell Biol. 2012, 199:437-451.
195. Senger D.L., Campenot R.B. Rapid retrograde tyrosine phosphorylation of trkA and other proteins in rat sympathetic neurons in compartmented cultures. J. Cell Biol. 1997, 138:411-421.
196. Sennvik K., Fastbom J., Blomberg M., Wahlund L.O., Winblad B., Benedikz E. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett. 2000, 278:169-172.
197. Shan X., Chiang P.M., Price D.L., Wong P.C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl. Acad. Sci. USA 2010, 107:16325-16330.
198. Sheng Z.H. Mitochondrial trafficking and anchoring in neurons: new insight and implications. J. Cell Biol. 2014, 204:1087-1098.
199. Shepheard S.R., Chataway T., Schultz D.W., Rush R.A., Rogers M.L. The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PloS One 2014, 9:e87398.
200. Shirvan A., Ziv I., Fleminger G., Shina R., He Z., Brudo I., Melamed E., Barzilai A. Semaphorins as mediators of neuronal apoptosis. J. Neurochem. 1999, 73:961-971.
201. Southam K.A., King A.E., Blizzard C.A., McCormack G.H., Dickson T.C. Microfluidic primary culture model of the lower motor neuron-neuromuscular junction circuit. J. Neurosci. Methods 2013, 218:164-169.
202. Spillane M., Ketschek A., Merianda T.T., Twiss J.L., Gallo G. Mitochondria coordinate sites of axon branching through localized intra-axonal protein synthesis. Cell. Rep. 2013, 5:1564-1575.
203. Sreedharan J., Brown R.H. Amyotrophic lateral sclerosis: problems and prospects. Ann. Neurol. 2013, 74:309-316.
204. Steel E. 'Ice Bucket Challenge' Donations for A.L.S. Research Top $41Million 2014, The New York Times, B2.
205. Steinacker P., Fang L., Kuhle J., Petzold A., Tumani H., Ludolph A.C., Otto M., Brettschneider J. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis. PloS One 2011, 6:e23600.
206. Steinacker P., Hendrich C., Sperfeld A.D., Jesse S., Lehnert S., Pabst A., von Arnim C.A., Mottaghy F.M., Uttner I., Tumani H., Ludolph A., Otto M. Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. J. Neural Transm. 2009, 116:1169-1178.
207. Stockmann M., Meyer-Ohlendorf M., Achberger K., Putz S., Demestre M., Yin H., Hendrich C., Linta L., Heinrich J., Brunner C., Proepper C., Kuh G.F., Baumann B., Langer T., Schwalenstocker B., Braunstein K.E., von Arnim C., Schneuwly S., Meyer T., Wong P.C., Boeckers T.M., Ludolph A.C., Liebau S. The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes. J. Neural Transm. 2013, 120:785-798.
208. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
209. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., Wyns S., Manka D., Vermeulen K., Van Den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E.M., Collen D., Moons L., Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 2005, 8:85-92.
210. Strey C.W., Spellman D., Stieber A., Gonatas J.O., Wang X., Lambris J.D., Gonatas N.K. Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am. J. Pathol. 2004, 165:1701-1718.
211. Stribl C., Samara A., Trumbach D., Peis R., Neumann M., Fuchs H., Gailus-Durner V., Hrabe de Angelis M., Rathkolb B., Wolf E., Beckers J., Horsch M., Neff F., Kremmer E., Koob S., Reichert A.S., Hans W., Rozman J., Klingenspor M., Aichler M., Walch A.K., Becker L., Klopstock T., Glasl L., Holter S.M., Wurst W., Floss T. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J. Biol. Chem. 2014, 289:10769-10784.
212. Strong M.J., Volkening K., Hammond R., Yang W., Strong W., Leystra-Lantz C., Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 2007, 35:320-327.
213. Sumitha R., Sidhu R.J., Sathyaprabha T.N., Nalini A., Raju T.R., Alladi P.A. Differential expression of microRNA-206 in the gastrocnemius and biceps brachii in response to CSF from sporadic amyotrophic lateral sclerosis patients. J. Neurol. Sci 2014, 345:254-256.
214. Taes I., Timmers M., Hersmus N., Bento-Abreu A., Van Den Bosch L., Van Damme P., Auwerx J., Robberecht W. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet. 2013, 22:1783-1790.
215. Tamagnone L., Artigiani S., Chen H., He Z., Ming G.I., Song H., Chedotal A., Winberg M.L., Goodman C.S., Poo M., Tessier-Lavigne M., Comoglio P.M. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999, 99:71-80.
216. Tamaoka A., Matsuno S., Ono S., Shimizu N., Shoji S. Increased amyloid betaprotein in the skin of patients with amyotrophic lateral sclerosis. J. Neurol. 2000, 247:633-635.
217. Tan W., Naniche N., Bogush A., Pedrini S., Trotti D., Pasinelli P. Small peptides against the mutant SOD1/Bcl-2 toxic mitochondrial complex restore mitochondrial function and cell viability in mutant SOD1-mediated ALS. J. Neurosci. 2013, 33:11588-11598.
218. Therrien M., Parker J.A. Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans. Front. Genet. 2014, 5:85.
219. Toivonen J.M., Manzano R., Olivan S., Zaragoza P., Garcia-Redondo A., Osta R. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PloS One 2014, 9:e89065.
220. Tortarolo M., Veglianese P., Calvaresi N., Botturi A., Rossi C., Giorgini A., Migheli A., Bendotti C. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 2003, 23:180-192.
221. Tripathi V.B., Baskaran P., Shaw C.E., Guthrie S. Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo. Neurobiol. Dis. 2014, 65:25-34.
222. Tsao W., Jeong Y.H., Lin S., Ling J., Price D.L., Chiang P.M., Wong P.C. Rodent models of TDP-43: recent advances. Brain Res. 2012, 1462:26-39.
223. Turner B.J., Cheah I.K., Macfarlane K.J., Lopes E.C., Petratos S., Langford S.J., Cheema S.S. Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J. Neurochem. 2003, 87:752-763.
224. Turner B.J., Murray S.S., Piccenna L.G., Lopes E.C., Kilpatrick T.J., Cheema S.S. Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice. J. Neurosci. Res. 2004, 78:193-199.
225. Vale R.D. The molecular motor toolbox for intracellular transport. Cell 2003, 112:467-480.
226. Vale R.D., Reese T.S., Sheetz M.P. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell 1985, 42:39-50.
227. Valenzuela-Fernandez A., Cabrero J.R., Serrador J.M., Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol. 2008, 18:291-297.
228. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
229. Vargas M.R., Johnson J.A. Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurother.: J. Am. Soc. Exp. Neurother. 2010, 7:471-481.
230. Vehvilainen P., Koistinaho J., Gundars G. Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014, 8:126.
231. Venkova K., Christov A., Kamaluddin Z., Kobalka P., Siddiqui S., Hensley K. Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2014, 73:702-713.
232. Veyrat-Durebex C., Corcia P., Dangoumau A., Laumonnier F., Piver E., Gordon P.H., Andres C.R., Vourc'h P., Blasco H. Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis. Mol. Neurobiol. 2014, 49:966-983.
233. von Zastrow M., Sorkin A. Signaling on the endocytic pathway. Curr. Opin. Cell Biol. 2007, 19:436-445.
234. Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013, 22:4706-4719.
235. Waterman-Storer C.M., Karki S., Holzbaur E.L. The p150Glued component of the dynactin complex binds to both microtubules and the actin-related protein centractin (Arp-1). Proc. Natl. Acad. Sci. USA 1995, 92:1634-1638.
236. Weaver C., Leidel C., Szpankowski L., Farley N.M., Shubeita G.T., Goldstein L.S. Endogenous GSK-3/shaggy regulates bidirectional axonal transport of the amyloid precursor protein. Traffic 2013, 14:295-308.
237. Wen H.L., Ting C.H., Liu H.C., Li H., Lin-Chao S. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy. Neurobiol. Dis. 2013, 52:94-103.
238. Williams A., Piaton G., Aigrot M.S., Belhadi A., Theaudin M., Petermann F., Thomas J.L., Zalc B., Lubetzki C. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?. Brain: J. Neurol. 2007, 130:2554-2565.
239. Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.
240. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999, 2:50-56.
241. Willis D., Li K.W., Zheng J.Q., Chang J.H., Smit A.B., Kelly T., Merianda T.T., Sylvester J., van Minnen J., Twiss J.L. Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J. Neurosci.: Off. J. Soc. Neurosci. 2005, 25:778-791.
242. Wu C.H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., Kost J.E., Gonzalez-Perez P., Fox A.D., Adams J., Taroni F., Tiloca C., Leclerc A.L., Chafe S.C., Mangroo D., Moore M.J., Zitzewitz J.A., Xu Z.S., van den Berg L.H., Glass J.D., Siciliano G., Cirulli E.T., Goldstein D.B., Salachas F., Meininger V., Rossoll W., Ratti A., Gellera C., Bosco D.A., Bassell G.J., Silani V., Drory V.E., Brown R.H., Landers J.E. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 2012, 488:499-503.
243. Xia C.H., Roberts E.A., Her L.S., Liu X., Williams D.S., Cleveland D.W., Goldstein L.S. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 2003, 161:55-66.
244. Xu S., Peng G., Wang Y., Fang S., Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol. Biol. Cell 2011, 22:291-300.
245. Yasuda K., Zhang H., Loiselle D., Haystead T., Macara I.G., Mili S. The RNA-binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J. Cell Biol. 2013, 203:737-746.
246. Yildiz A., Tomishige M., Vale R.D., Selvin P.R. Kinesin walks hand-over-hand. Science 2004, 303:676-678.
247. Yoon E.J., Park H.J., Kim G.Y., Cho H.M., Choi J.H., Park H.Y., Jang J.Y., Rhim H.S., Kang S.M. Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis. Exp. Mol. Med. 2009, 41:611-617.
248. Yoshimura A., Fujii R., Watanabe Y., Okabe S., Fukui K., Takumi T. Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines. Curr. Biol.: CB 2006, 16:2345-2351.
249. Youker R.T., Bruns J.R., Costa S.A., Rbaibi Y., Lanni F., Kashlan O.B., Teng H., Weisz O.A. Multiple motifs regulate apical sorting of p75 via a mechanism that involves dimerization and higher-order oligomerization. Mol. Biol. Cell 2013, 24:1996-2007.
250. Zahavi, E.E.I., A.; Ben-Yaakov, K.; Gluska, S.; Gradus Pery T; Perlson, E., Spatial Function of GDNF Demonstrated by Compartmental Microfluidic Neuromuscular Co-Culture System. submitted.
251. Zala D., Hinckelmann M.V., Yu H., Lyra da Cunha M.M., Liot G., Cordelieres F.P., Marco S., Saudou F. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 2013, 152:479-491.
252. Zheng C., Skold M.K., Li J., Nennesmo I., Fadeel B., Henter J.I. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Biochem. Biophys. Res. Commun. 2007, 363:989-993.